| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |